Cargando…

Application and clinical efficacy of Sufu medical chitosan hydrogel dressing in radiation skin damage caused by radiotherapy for cervical cancer

OBJECTIVES: To investigate the benefits of Sufu medical chitosan hydrogel dressing(Sufu) in the prevention and control of radiation skin damage during radiotherapy for cervical cancer as a combined modality. METHODS: Ninety-seven cervical cancer patients who underwent radiotherapy at the Cancer Hosp...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Xiaodan, Hu, Xiufen, Dong, Xiaojing, Li, Shenjie, Ni, Yali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Professional Medical Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676621/
https://www.ncbi.nlm.nih.gov/pubmed/36415280
http://dx.doi.org/10.12669/pjms.38.8.5569
_version_ 1784833640823259136
author He, Xiaodan
Hu, Xiufen
Dong, Xiaojing
Li, Shenjie
Ni, Yali
author_facet He, Xiaodan
Hu, Xiufen
Dong, Xiaojing
Li, Shenjie
Ni, Yali
author_sort He, Xiaodan
collection PubMed
description OBJECTIVES: To investigate the benefits of Sufu medical chitosan hydrogel dressing(Sufu) in the prevention and control of radiation skin damage during radiotherapy for cervical cancer as a combined modality. METHODS: Ninety-seven cervical cancer patients who underwent radiotherapy at the Cancer Hospital of China Medical University between May 2017 and November 2018 were recruited according to given inclusion and exclusion criteria. The patients were assigned to a control group (n=48, washing the perineal area with normal saline) and an observation group (n=49, application of Sufu onto the site of radiotherapy in addition to washing the perineal area with normal saline). The treatment regimens for the two groups continued until the end of radiotherapy. A comparison of the RTOG (Radiation Therapy Oncology Group) grading of acute radiation-induced skin reactions (ARISRs), pain intensity (measured by the verbal rating scale (VRS)) and post-treatment wound healing was drawn between the two groups. RESULTS: In the observation group, 81.6% (40/49) of the patients had radiation dermatitis, which was significantly lower than the incidence rate (95.8%, 46/48) in the control group (P <0.05). The observation group was at higher risk of radiation dermatitis when given a high radiation dose, while the control group was more likely to have radiation dermatitis when administered with a moderate radiation dose (P <0.05). The median time of occurrence of pain and the median time of onset of skin reactions were significantly later in the observation group as compared with the control group (P <0.05, respectively). In the observation group, the pain relief rate was 92.50% at Day-3, and the wound healing rate was 95.0% at Day-7, significantly higher than in the control group (73.9% and 80.4%) (P <0.05, respectively). CONCLUSIONS: During radiotherapy for cervical cancer, Sufu can effectively prevent and control radiation-induced skin and mucous membrane damage, delay the onset of radiation dermatitis and substantially reduce the incidence rate, relieve radiation dermatitis and pain and promote wound healing.
format Online
Article
Text
id pubmed-9676621
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Professional Medical Publications
record_format MEDLINE/PubMed
spelling pubmed-96766212022-11-21 Application and clinical efficacy of Sufu medical chitosan hydrogel dressing in radiation skin damage caused by radiotherapy for cervical cancer He, Xiaodan Hu, Xiufen Dong, Xiaojing Li, Shenjie Ni, Yali Pak J Med Sci Original Article OBJECTIVES: To investigate the benefits of Sufu medical chitosan hydrogel dressing(Sufu) in the prevention and control of radiation skin damage during radiotherapy for cervical cancer as a combined modality. METHODS: Ninety-seven cervical cancer patients who underwent radiotherapy at the Cancer Hospital of China Medical University between May 2017 and November 2018 were recruited according to given inclusion and exclusion criteria. The patients were assigned to a control group (n=48, washing the perineal area with normal saline) and an observation group (n=49, application of Sufu onto the site of radiotherapy in addition to washing the perineal area with normal saline). The treatment regimens for the two groups continued until the end of radiotherapy. A comparison of the RTOG (Radiation Therapy Oncology Group) grading of acute radiation-induced skin reactions (ARISRs), pain intensity (measured by the verbal rating scale (VRS)) and post-treatment wound healing was drawn between the two groups. RESULTS: In the observation group, 81.6% (40/49) of the patients had radiation dermatitis, which was significantly lower than the incidence rate (95.8%, 46/48) in the control group (P <0.05). The observation group was at higher risk of radiation dermatitis when given a high radiation dose, while the control group was more likely to have radiation dermatitis when administered with a moderate radiation dose (P <0.05). The median time of occurrence of pain and the median time of onset of skin reactions were significantly later in the observation group as compared with the control group (P <0.05, respectively). In the observation group, the pain relief rate was 92.50% at Day-3, and the wound healing rate was 95.0% at Day-7, significantly higher than in the control group (73.9% and 80.4%) (P <0.05, respectively). CONCLUSIONS: During radiotherapy for cervical cancer, Sufu can effectively prevent and control radiation-induced skin and mucous membrane damage, delay the onset of radiation dermatitis and substantially reduce the incidence rate, relieve radiation dermatitis and pain and promote wound healing. Professional Medical Publications 2022 /pmc/articles/PMC9676621/ /pubmed/36415280 http://dx.doi.org/10.12669/pjms.38.8.5569 Text en Copyright: © Pakistan Journal of Medical Sciences https://creativecommons.org/licenses/by/3.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0 (https://creativecommons.org/licenses/by/3.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
He, Xiaodan
Hu, Xiufen
Dong, Xiaojing
Li, Shenjie
Ni, Yali
Application and clinical efficacy of Sufu medical chitosan hydrogel dressing in radiation skin damage caused by radiotherapy for cervical cancer
title Application and clinical efficacy of Sufu medical chitosan hydrogel dressing in radiation skin damage caused by radiotherapy for cervical cancer
title_full Application and clinical efficacy of Sufu medical chitosan hydrogel dressing in radiation skin damage caused by radiotherapy for cervical cancer
title_fullStr Application and clinical efficacy of Sufu medical chitosan hydrogel dressing in radiation skin damage caused by radiotherapy for cervical cancer
title_full_unstemmed Application and clinical efficacy of Sufu medical chitosan hydrogel dressing in radiation skin damage caused by radiotherapy for cervical cancer
title_short Application and clinical efficacy of Sufu medical chitosan hydrogel dressing in radiation skin damage caused by radiotherapy for cervical cancer
title_sort application and clinical efficacy of sufu medical chitosan hydrogel dressing in radiation skin damage caused by radiotherapy for cervical cancer
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676621/
https://www.ncbi.nlm.nih.gov/pubmed/36415280
http://dx.doi.org/10.12669/pjms.38.8.5569
work_keys_str_mv AT hexiaodan applicationandclinicalefficacyofsufumedicalchitosanhydrogeldressinginradiationskindamagecausedbyradiotherapyforcervicalcancer
AT huxiufen applicationandclinicalefficacyofsufumedicalchitosanhydrogeldressinginradiationskindamagecausedbyradiotherapyforcervicalcancer
AT dongxiaojing applicationandclinicalefficacyofsufumedicalchitosanhydrogeldressinginradiationskindamagecausedbyradiotherapyforcervicalcancer
AT lishenjie applicationandclinicalefficacyofsufumedicalchitosanhydrogeldressinginradiationskindamagecausedbyradiotherapyforcervicalcancer
AT niyali applicationandclinicalefficacyofsufumedicalchitosanhydrogeldressinginradiationskindamagecausedbyradiotherapyforcervicalcancer